Published in J Infect Dis on May 01, 1978
Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci U S A (1989) 10.84
Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infect Immun (1985) 6.74
Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun (1983) 6.43
Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun (1983) 3.49
Role of nonhost environments in the lifestyles of Salmonella and Escherichia coli. Appl Environ Microbiol (2003) 3.10
Molecular characterization of plasmids from virulent and spontaneously occurring avirulent colonial variants of Shigella flexneri. Infect Immun (1979) 2.93
Identification of a chromosomal gene controlling temperature-regulated expression of Shigella virulence. Proc Natl Acad Sci U S A (1988) 2.81
Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun (1984) 2.23
Identification of regions on a 230-kilobase plasmid from enteroinvasive Escherichia coli that are required for entry into HEp-2 cells. Infect Immun (1988) 1.69
Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization. J Clin Microbiol (1988) 1.57
Cloning of regions required for contact hemolysis and entry into LLC-MK2 cells from Shigella sonnei form I plasmid: virF is a positive regulator gene for these phenotypes. Infect Immun (1989) 1.55
Molecular cloning of epithelial cell invasion determinants from enterotoxigenic Escherichia coli. Infect Immun (1992) 1.52
Induction of attachment-independent biofilm formation and repression of Hfq expression by low-fluid-shear culture of Staphylococcus aureus. Appl Environ Microbiol (2011) 1.04
Diarrheagenic Escherichia coli. Braz J Microbiol (2016) 0.84
Virulence versus resistance. Bull N Y Acad Med (1987) 0.80
EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY. J Bacteriol (1964) 19.60
Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun (1982) 13.55
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet (1978) 10.29
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94
Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun (1983) 6.43
Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect Immun (1981) 6.40
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis (1974) 6.38
Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans. Infect Immun (1972) 6.21
Protein synthesis in HeLa or Henle 407 cells infected with Shigella dysenteriae 1, Shigella flexneri 2a, or Salmonella typhimurium W118. Infect Immun (1981) 5.39
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet (1983) 4.89
Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen. Infect Immun (1980) 4.87
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun (1983) 4.82
Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis. J Infect Dis (1972) 4.60
Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol (1965) 4.42
Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J Infect Dis (1973) 4.22
Plaque formation by virulent Shigella flexneri. Infect Immun (1985) 4.16
Fecal leukocytes in diarrheal illness. Ann Intern Med (1972) 3.89
Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun (1986) 3.87
Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli. Infect Immun (1985) 3.78
Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis (1989) 3.71
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun (1972) 3.33
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol (1980) 3.31
Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun (1976) 3.30
Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton protein. Infect Immun (1989) 3.24
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
Molecular characterization of plasmids from virulent and spontaneously occurring avirulent colonial variants of Shigella flexneri. Infect Immun (1979) 2.93
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest (1973) 2.78
Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis (1974) 2.73
Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother (1976) 2.71
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri. J Bacteriol (1966) 2.60
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Exerimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri. An electron microscope study. Am J Pathol (1968) 2.53
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg (1979) 2.51
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49
Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev (1966) 2.42
Plasmid-mediated invasiveness of "Shigella-like" Escherichia coli. Ann Microbiol (Paris) (1982) 2.38
Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol (1966) 2.23
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun (1981) 2.15
Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 2.08
The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med (1971) 2.07
Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride. JAMA (1968) 1.93
Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol (1969) 1.91
Invasive enteric pathogens. Rev Infect Dis (1983) 1.91
Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infect Immun (1979) 1.91
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis (1987) 1.90
Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. J Immunol (1979) 1.90
Species specificity of in vitro Escherichia coli adherence to host intestinal cell membranes and its correlation with in vivo colonization and infectivity. Infect Immun (1980) 1.89
Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci (1973) 1.84
Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology (1975) 1.83
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Genetic transfer of a mucosal adherence factor (R1) from an enteropathogenic Escherichia coli strain into a Shigella flexneri strain and the phenotypic suppression of this adherence factor. J Infect Dis (1983) 1.78
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75
Cutaneous responses to cholera skin toxin in man. I. Responses in unimmunized American males. J Infect Dis (1972) 1.74
Phage conversion of Shigella flexneri group antigens. Infect Immun (1975) 1.74
Local and systemic antibody responses to Shigella infection in rhesus monkeys. J Infect Dis (1987) 1.73
Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol (1986) 1.72
Pathogenesis of Salmonella-mediated intestinal fluid secretion. Activation of adenylate cyclase and inhibition by indomethacin. Gastroenterology (1975) 1.71
Salmonella gastroenteritis in rhesus monkeys. Arch Pathol (1966) 1.70
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect Immun (1990) 1.64
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J Infect Dis (1995) 1.64
BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1975) 1.61
Laboratory Vibrio cholerae infection in the United States. JAMA (1966) 1.59
Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med (1972) 1.57
Pathophysiology of Salmonella diarrhea in the Rhesus monkey: Intestinal transport, morphological and bacteriological studies. Gastroenterology (1974) 1.56
Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella. J Immunol (1980) 1.56
Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells. Am J Clin Nutr (1980) 1.52
Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect Immun (1984) 1.52
Invasive enteropathic Escherichia coli dysentery. An outbreak in 28 adults. Ann Intern Med (1973) 1.47
Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med (1967) 1.46
Quantitation of the adherence of an enteropathogenic Escherichia coli to isolated rabbit intestinal brush borders. Infect Immun (1979) 1.45
Lack of enhanced oxygen consumption by polymorphonuclear leukocytes on phagocytosis of virulent Salmonella typhi. Science (1972) 1.44
Genetic susceptibility to cholera. Ann Hum Biol (1980) 1.44
Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion. J Infect Dis (1974) 1.44
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol (1969) 1.42
Peptic ulcer disease: a bacterial infection? N Engl J Med (1987) 1.41
The role of Peyer's patches in the local immune response of rabbit ileum to live bacteria. J Immunol (1978) 1.41
Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis (1973) 1.39
Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J Infect Dis (1972) 1.39
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect Immun (1992) 1.39